{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:39:14Z","timestamp":1778074754482,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302829"],"award-info":[{"award-number":["81302829"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500530"],"award-info":[{"award-number":["81500530"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.clim.2018.10.001","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T17:39:37Z","timestamp":1538761177000},"page":"179-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Fra-2 is a novel candidate drug target expressed in the podocytes of lupus nephritis"],"prefix":"10.1016","volume":"197","author":[{"given":"Changliang","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunjie","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingmeng","family":"Pi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouchao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Furong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2018.10.001_bb0005","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/0961203309357763","article-title":"Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis","volume":"19","author":"Lee","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2018.10.001_bb0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00005792-199905000-00003","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus","volume":"78","author":"Cervera","year":"1999","journal-title":"Medicine"},{"key":"10.1016\/j.clim.2018.10.001_bb0015","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2353\/ajpath.2006.051329","article-title":"Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells","volume":"168","author":"Kalaaji","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clim.2018.10.001_bb0020","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2009080805","article-title":"Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis","volume":"21","author":"Yung","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2018.10.001_bb0025","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1681\/ASN.2014030233","article-title":"Deficiency of Fibroblast Growth Factor-Inducible 14 (Fn14) Preserves the Filtration Barrier and Ameliorates Lupus Nephritis","volume":"26","author":"Xia","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2018.10.001_bb0030","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1038\/sj.onc.1206570","article-title":"Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility","volume":"22","author":"Tkach","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.clim.2018.10.001_bb0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1242\/dev.111.2.253","article-title":"Patterns of epithelial expression of Fos protein suggest important role in the transition from viable to cornified cell during keratinization","volume":"111","author":"Fisher","year":"1991","journal-title":"Development"},{"key":"10.1016\/j.clim.2018.10.001_bb0040","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/sj.onc.1206266","article-title":"The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression","volume":"22","author":"Ferrara","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.clim.2018.10.001_bb0045","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1006\/viro.1997.8798","article-title":"TNFalpha cooperates with the protein kinase a pathway to synergistically increase HIV-1 LTR transcription via downstream TRE-like cAMP response elements","volume":"237","author":"Rabbi","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.clim.2018.10.001_bb0050","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1038\/sj.onc.1204389","article-title":"AP-1 in mouse development and tumorigenesis","volume":"20","author":"Jochum","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.clim.2018.10.001_bb0055","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1038\/sj.onc.1210984","article-title":"Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia","volume":"27","author":"Nakayama","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.clim.2018.10.001_bb0060","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.ejca.2010.02.008","article-title":"The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells","volume":"46","author":"Schroder","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.clim.2018.10.001_bb0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10549-007-9559-y","article-title":"Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility","volume":"107","author":"Milde-Langosch","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.clim.2018.10.001_bb0070","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/cdd.2013.198","article-title":"Fra-2\/AP-1 controls adipocyte differentiation and survival by regulating PPARgamma and hypoxia","volume":"21","author":"Luther","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.clim.2018.10.001_bb0075","doi-asserted-by":"crossref","first-page":"15227","DOI":"10.1074\/jbc.M110.201996","article-title":"Selective genomic targeting by FRA-2\/FOSL2 transcription factor: regulation of the Rgs4 gene is mediated by a variant activator protein 1 (AP-1) promoter sequence\/CREB-binding protein (CBP) mechanism","volume":"286","author":"Davies","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2018.10.001_bb0080","series-title":"Ten Common Mistakes in the Management of Lupus Nephritis, American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation","first-page":"667","volume":"vol. 63","author":"Bose","year":"2014"},{"key":"10.1016\/j.clim.2018.10.001_bb0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor","volume":"14","author":"Wei","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2018.10.001_bb0090","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.yexmp.2015.03.020","article-title":"Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu","volume":"98","author":"Lan","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.clim.2018.10.001_bb0095","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.1401796","article-title":"Vizantin Inhibits Endotoxin-Mediated Immune responses via the TLR 4\/MD-2 complex","volume":"193","author":"Oda","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2018.10.001_bb0100","doi-asserted-by":"crossref","first-page":"F127","DOI":"10.1152\/ajprenal.00108.2012","article-title":"B7-1 expression regulates the hypoxia-driven cytoskeleton rearrangement in glomerular podocytes","volume":"304","author":"Chang","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.clim.2018.10.001_bb0105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/B:BREA.0000032982.49024.71","article-title":"The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas","volume":"86","author":"Milde-Langosch","year":"2004","journal-title":"Breast Cancer Res. Treat."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2018.10.001_bb0110","doi-asserted-by":"crossref","first-page":"i86","DOI":"10.1136\/ard.2009.119396","article-title":"Bone development and inflammatory disease is regulated by AP-1 (Fos\/Jun)","volume":"69","author":"Wagner","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2018.10.001_bb0115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/art.25056","article-title":"The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis","volume":"62","author":"Reich","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.10.001_bb0120","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1161\/CIRCULATIONAHA.109.855114","article-title":"Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis","volume":"120","author":"Maurer","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.clim.2018.10.001_bb0125","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/annrheumdis-2011-200940","article-title":"Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis","volume":"71","author":"Maurer","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2018.10.001_bb0130","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.ejca.2005.08.008","article-title":"The Fos family of transcription factors and their role in tumourigenesis","volume":"41","author":"Milde-Langosch","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.clim.2018.10.001_bb0135","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.autrev.2011.04.027","article-title":"Refractory disease in systemic lupus erythematosus","volume":"10","author":"Campar","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2018.10.001_bb0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrd4227","article-title":"Systemic lupus erythematosus and lupus nephritis","volume":"13","author":"Koutsokeras","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.clim.2018.10.001_bb0145","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/BOR.0000000000000089","article-title":"The pathogenesis, diagnosis and treatment of lupus nephritis","volume":"26","author":"Schwartz","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.clim.2018.10.001_bb0150","series-title":"Role of Podocytes in Lupus Nephritis, Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association","first-page":"3607","volume":"vol. 24","author":"Trivedi","year":"2009"},{"key":"10.1016\/j.clim.2018.10.001_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055980","article-title":"Protective effects of the mTOR inhibitor everolimus on cytoskeletal injury in human podocytes are mediated by RhoA signaling","volume":"8","author":"Jeruschke","year":"2013","journal-title":"PLoS One"},{"issue":"2011","key":"10.1016\/j.clim.2018.10.001_bb0160","first-page":"271694","article-title":"Murine models of systemic lupus erythematosus","author":"Perry","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.clim.2018.10.001_bb0165","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1128\/CDLI.4.5.572-578.1997","article-title":"Chronic administration of dexamethasone results in Fc receptor up-regulation and inhibition of class I antigen expression on macrophages from MRL\/lpr autoimmune mice","volume":"4","author":"Zuckerman","year":"1997","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.clim.2018.10.001_bb0170","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI20402","article-title":"Induction of B7-1 in podocytes is associated with nephrotic syndrome","volume":"113","author":"Reiser","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2018.10.001_bb0175","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","article-title":"The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A","volume":"14","author":"Faul","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2018.10.001_bb0180","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/sj.ki.5001625","article-title":"Screening and identification of substances that regulate nephrin gene expression using engineered reporter podocytes","volume":"70","author":"Yamauchi","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2018.10.001_bb0185","doi-asserted-by":"crossref","first-page":"F1436","DOI":"10.1152\/ajprenal.00512.2009","article-title":"Suppression of nephrin expression by TNF-alpha via interfering with the cAMP-retinoic acid receptor pathway","volume":"298","author":"Saito","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618303887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618303887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T11:43:24Z","timestamp":1662205404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661618303887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":37,"alternative-id":["S1521661618303887"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2018.10.001","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fra-2 is a novel candidate drug target expressed in the podocytes of lupus nephritis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2018.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}